BioSpace News Archive

Composite score and relevant sub-scores in the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) showed sustained improvements at Week 48 and Week 72

Co-Founders kick-start global Aurora Movement by welcoming 2017 Aurora Prize Laureate to represent organization

Health Recovery Solutions (HRS) has expanded their telehealth offerings to include tablet and mobile solutions. The HRS platform now consists of three tiers: PatientConnect Complete, the original HRS solution that includes a tablet and Bluetooth peripheral devices.

Funding to accelerate InterVenn’s development of its AI-driven mass spectrometry platform that measures glycoproteomic markers that have been strongly linked to tumor development and progression.

Multi-year agreement focuses on Morphomer tau aggregation inhibitors, for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases.

Rodin Therapeutics today announced the initiation of a Phase 1 clinical trial of the company’s lead candidate, RDN-929, a potent and selective HDAC-CoREST inhibitor.

Snead has served as Interim Chief Financial Officer since June 2018

Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2018.

Encompass Health Corp. (NYSE: EHC) today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference being held Jan. 7-10, 2019, in San Francisco, California.

ORHub, Inc. (OTC: ORHB) (the “Company” or “ORHub”), a SaaS-based healthcare data analytics company uniquely focused on the business of surgery to improve the profitability of health systems, hospitals and ambulatory surgery centers (ASCs), today announces that Surgical Spotlight™ helps medical facilities to meet new Meaningful Use Stage 3 (MU3) requirements put forth by the Centers for Medicare and Medicaid (CMS).